Same Indication

Nivolumab vs Vancomycin

Nivolumab vs Vancomycin: Overview

This comparison examines the pharmacological differences between Nivolumab and Vancomycin.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Vancomycin: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Vancomycin — 4-6 hours.

Chemical Properties

Molecular Formula: Vancomycin — C66H75Cl2N9O24.

Molecular Weight: Vancomycin — 1449.2500 g/mol.

Type: Nivolumab — Antibody; Vancomycin — Small molecule.